The Cureus Journal of Medical Science has published a narrative review examining how insulin resistance and muscle protein metabolism relate to physiotherapy outcomes in people with type 2 diabetes. The review appeared on Friday, 23 October 2026. It brings together the topics of insulin resistance, muscle protein metabolism and physiotherapy outcomes in type 2 diabetes mellitus.
The review sits alongside a wave of recent research into the biology behind insulin resistance. Nature reported work indicating that Miro1 mediates skeletal muscle insulin resistance in type 2 diabetes, a finding also covered by News-Medical, which described the Miro1 protein as linked to insulin resistance in the condition. Inside Precision Medicine, meanwhile, reported that a new molecular target for treating type 2 diabetes had been identified. Diabetes In Control reported on CA8 in type 2 diabetes, describing a new link between two organs.
Taken together, the coverage points to continuing interest in the molecular and metabolic mechanisms of type 2 diabetes, including those operating in skeletal muscle. The Cureus review focuses on the clinical side of that picture, considering physiotherapy outcomes in the context of insulin resistance and muscle protein metabolism. The available summary does not detail the review's specific findings or conclusions.
What to watch next: whether the molecular findings reported by Nature and others are followed by studies that connect them to rehabilitation and physiotherapy results in patients with type 2 diabetes.
